Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT01843816Completed

The Effect of Body Shape on Tragus-Wall Measurement

Role: lead

NCT00961870Not ApplicableCompleted

Effect of Radius on Alpha Motor Neuron Excitability

Role: lead

NCT01098799Completed

Urotensin II in Chronic Kidney Diseases and Kidney Transplants

Role: lead

NCT01102205Completed

Evaluation of Oxidative Stress and Effect of Levothyroxine Treatment on Oxidative Stress in Hashimoto Disease

Role: lead

NCT01833468Completed

Functional Limitations Due To The Foot Involvement In Spondyloarthritis

Role: lead

NCT01103232Not ApplicableCompleted

Cross-Education Of Contralateral Antagonists

Role: lead

NCT01097122Not ApplicableCompleted

Effects Of Unilateral Vibration On Contralateral Forearm Muscle Activity

Role: lead

All 7 trials loaded